NASDAQ:HLTH Cue Health (HLTH) Stock Price, News & Analysis → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free HLTH Stock Alerts $0.10 -0.02 (-17.18%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$0.09▼$0.1450-Day Range$0.10▼$0.2952-Week Range$0.09▼$0.89Volume38.70 million shsAverage Volume1.18 million shsMarket Capitalization$15.34 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Cue Health alerts: Email Address Cue Health MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.46% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.15Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.13) to ($0.39) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.74 out of 5 starsMedical Sector878th out of 921 stocksAnalytical Instruments Industry26th out of 29 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Cue Health.Read more about Cue Health's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.46% of the float of Cue Health has been sold short.Short Interest Ratio / Days to CoverCue Health has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cue Health has recently increased by 10.76%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCue Health does not currently pay a dividend.Dividend GrowthCue Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HLTH. Previous Next 2.1 News and Social Media Coverage News SentimentCue Health has a news sentiment score of -0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cue Health this week, compared to 1 article on an average week.Search Interest3 people have searched for HLTH on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows1 people have added Cue Health to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cue Health insiders have not sold or bought any company stock.Percentage Held by Insiders12.50% of the stock of Cue Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions45.49% of the stock of Cue Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Cue Health's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Cue Health are expected to grow in the coming year, from ($1.13) to ($0.39) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cue Health is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cue Health is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCue Health has a P/B Ratio of 0.06. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. About Cue Health Stock (NASDAQ:HLTH)Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.Read More HLTH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HLTH Stock News HeadlinesMay 14, 2024 | msn.comCue Health slips as FDA warns against COVID-19 testsMay 13, 2024 | nasdaq.comCue Health Receives FDA Warning Letter Regarding Emergency Use Authorized COVID-19 TestMay 13, 2024 | businesswire.comCue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)May 11, 2024 | americanbankingnews.comCue Health (HLTH) Set to Announce Earnings on MondayMay 1, 2024 | marketwatch.comCue Health to Cut About Half of WorkforceApril 29, 2024 | finance.yahoo.comCue Health to Announce First Quarter Financial ResultsMarch 22, 2024 | markets.businessinsider.comCue Health’s Hold Rating Amidst Leadership Changes and FDA SetbacksMarch 20, 2024 | finance.yahoo.comCue Health Announces Strategic Actions to Position Company for Next StageMarch 20, 2024 | businesswire.comCue Health Announces Strategic Actions to Position Company for Next StageMarch 18, 2024 | investorplace.com3 Promising Penny Stocks You Can Pick Up for Less Than a QuarterMarch 16, 2024 | investing.comBTIG downgrades Cue Health stock amid cash runway and FDA approval concernsMarch 16, 2024 | seekingalpha.comCue Health, Inc. (HLTH) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comCue Health Inc. (NASDAQ:HLTH) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comHLTH Mar 2024 2.500 putMarch 14, 2024 | markets.businessinsider.comBuy Rating Affirmed for Guardant Health Amid Strong Shield Test Prospects and Positive ECLIPSE Study ResultsMarch 13, 2024 | benzinga.comCue Health: Q4 Earnings InsightsMarch 13, 2024 | businesswire.comCue Health Reports Fourth Quarter 2023 Financial ResultsMarch 6, 2024 | finance.yahoo.comHLTH Sep 2024 7.500 callFebruary 28, 2024 | finance.yahoo.comCue Health to Announce Fourth Quarter and Full Year 2023 Financial ResultsFebruary 23, 2024 | benzinga.comCue Health Stock (NASDAQ:HLTH) Insider TradesFebruary 20, 2024 | finance.yahoo.comHLTH Sep 2024 2.500 callFebruary 16, 2024 | finance.yahoo.comCue Health Announces Appointment of Rishi Reddy to Board of DirectorsFebruary 16, 2024 | businesswire.comCue Health Announces Appointment of Rishi Reddy to Board of DirectorsJanuary 9, 2024 | morningstar.comCue Health Inc HLTHJanuary 3, 2024 | markets.businessinsider.comBTIG Reaffirms Their Buy Rating on Cue Health (HLTH)See More Headlines Receive HLTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cue Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/13/2024Today5/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryN/A Current SymbolNASDAQ:HLTH CUSIPN/A CIK1628945 Webwww.cuehealth.com Phone858-412-8151FaxN/AEmployees726Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-373,460,000.00 Net Margins-526.48% Pretax Margin-519.72% Return on Equity-67.82% Return on Assets-53.79% Debt Debt-to-Equity RatioN/A Current Ratio2.54 Quick Ratio2.22 Sales & Book Value Annual Sales$70.94 million Price / Sales0.22 Cash FlowN/A Price / Cash FlowN/A Book Value$1.62 per share Price / Book0.06Miscellaneous Outstanding Shares159,090,000Free Float139,206,000Market Cap$15.34 million OptionableOptionable Beta1.30 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Clint Sever (Age 39)Co-Founder & CEO Comp: $906.39kMr. Ayub K. Khattak (Age 39)Co-Founder & Director Comp: $1.06MMr. Christopher K. Achar (Age 38)Chief Business Officer & Director Mr. Aasim Javed (Age 40)CFO, Treasurer & Principal Financial Officer Mr. Randall E. Pollard (Age 52)Controller & Principal Accounting Officer Ms. Lorna WilliamsVice President of Investor RelationsMs. Erica Palsis Esq. (Age 38)General Counsel & Corporate Secretary Ms. Eileen SheilChief Communications OfficerMr. Nitin DuggalChief Marketing OfficerMs. Allison F. Blackwell (Age 59)Chief Human Resources Officer More ExecutivesKey CompetitorsAccelerate DiagnosticsNASDAQ:AXDXTalis BiomedicalNASDAQ:TLISSingular Genomics SystemsNASDAQ:OMICPrecipioNASDAQ:PRPOTelesis BioNASDAQ:TBIOView All CompetitorsInstitutional OwnershipMirae Asset Global Investments Co. Ltd.Bought 185,557 shares on 5/1/2024Ownership: 0.117%B. Riley Wealth Advisors Inc.Bought 64,000 shares on 3/15/2024Ownership: 0.210%View All Institutional Transactions HLTH Stock Analysis - Frequently Asked Questions Should I buy or sell Cue Health stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cue Health in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HLTH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLTH, but not buy additional shares or sell existing shares. View HLTH analyst ratings or view top-rated stocks. How have HLTH shares performed in 2024? Cue Health's stock was trading at $0.1625 at the start of the year. Since then, HLTH stock has decreased by 40.7% and is now trading at $0.0964. View the best growth stocks for 2024 here. How were Cue Health's earnings last quarter? Cue Health Inc. (NASDAQ:HLTH) issued its quarterly earnings data on Wednesday, March, 13th. The company reported ($0.32) EPS for the quarter, beating analysts' consensus estimates of ($0.45) by $0.13. The company earned $18.80 million during the quarter, compared to analysts' expectations of $17.60 million. Cue Health had a negative net margin of 526.48% and a negative trailing twelve-month return on equity of 67.82%. What guidance has Cue Health issued on next quarter's earnings? Cue Health issued an update on its first quarter 2024 earnings guidance on Wednesday, March, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $9.0 million-$11.0 million, compared to the consensus revenue estimate of $28.9 million. When did Cue Health IPO? Cue Health (HLTH) raised $200 million in an initial public offering (IPO) on Friday, September 24th 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share. Who are Cue Health's major shareholders? Cue Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include Mirae Asset Global Investments Co. Ltd. (0.12%). View institutional ownership trends. How do I buy shares of Cue Health? Shares of HLTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HLTH) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.